While neither the Common Rule nor FDA regulations prescribe IRB fees, both establish extensive oversight requirements that need ongoing institutional support. Fee schedules serve as a compliant mechanism to recover the costs of fulfilling these federally mandated review and monitoring activities, provided they are applied transparently and without creating conflicts of interest. This workshop will explore how IRB fees must be applied transparently and without creating undue influence, while also supporting cooperative and single IRB responsibilities.
Presenters will discuss methods for developing, managing, and monitoring fee schedules while avoiding pitfalls that may arise from inconsistent billing or lack of documentation. Participants are encouraged to bring examples of their current fee schedules for hands-on group discussions.
Members: $45Nonmembers: $95